EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M; EANO Executive Board and ESMO Guidelines Committee. Ann Oncol. 2021 Aug.

Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study). Ahn GS, Hwang K, Kim TM, Park CK, Chang JH, Jung TY, Kim JH, Nam DH, Kim SH, Yoo H, Hong YK, Kim EY, Lee DE, Joo J, Kim YJ, Choe G, Choi BS, Kang SG, Kim JH, Kim CY. Cancer Res Treat. 2021 Jul 6.

High-dose methotrexate monotherapy for newly diagnosed primary central nervous system
lymphoma: 15-year multicenter experience. Yoon WS, Park JS, Kim YI, Chung DS, Jeun SS, Hong YK, Yang SH. Asia Pac J Clin Oncol. 2021 Feb.

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub‑group analysis of Korean patients in the EF‑14 phase 3 trial. Chae-Yong Kim, Sun Ha Paek, Do-Hyun Nam, Jong-Hee Chang, Yong-Kil Hong, Jeong Hoon Kim, Oh Lyong Kim, Se-Hyuk Kim. J Neurooncol / 2020

Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study). Kihwan Hwang, Tae Min Kim, Chul-Kee Park, Jong Hee Chang, Tae-Young Jung, Jin Hee Kim, Do-Hyun Nam, Se-Hyuk Kim, Heon Yoo, Yong-Kil Hong, Eun-Young Kim, Dong-Eun Lee, Jungnam Joo, Yu Jung Kim, Gheeyoung Choe, Byung Se Choi, Seok-Gu Kang, Jeong Hoon Kim, Chae-Yong Kim. Cancer Res Treat / 2020

Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells. So Jung Sung, Hyun-Kyung Kim, Yong-Kil Hong, Young Ae Joe. Biomol Ther (Seoul) / 2019

Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation. Hyun-Kyung Kim, Purevjargal Naidansuren, Seung Woo Lee, Rae-Kwon Kim, Su-Jae Lee, Suk Keun Lee, Yong-Kil Hong, Young Ae Joe. Oncotarget / 2018

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome. Michael Weller, Louis Burt Nabors, Thierry Gorlia, Henning Leske, Elisabeth Rushing, Pierre Bady, Christine Hicking, James Perry, Yong-Kil Hong, Patrick Roth, Wolfgang Wick, Simon L Goodman, Monika E Hegi, Martin Picard, Holger Moch, Josef Straub, Roger Stupp. Oncotarget / 2016

Parasellar Extension Grades and Surgical Extent in Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas : A Single Surgeon’s Consecutive Series with the Aspects of Reliability and Clinical Validity. Sang-Hyo Lee, Jae-Sung Park, Song Lee, Sung-Won Kim, Yong-Kil Hong. J Korean Neurosurg Soc / 2016

The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Seung Woo Lee, Hyun-Kyung Kim, Na-Hyeon Lee, Hee-Yeon Yi, Hong-Sug Kim, Sung Hee Hong, Yong-Kil Hong, Young Ae Joe. Cancer Lett / 2015

Modified Graded Repair of Cerebrospinal Fluid Leaks in Endoscopic Endonasal Transsphenoidal Surgery. Jae-Hyun Park, Jai Ho Choi, Young-Il Kim, Sung Won Kim, Yong-Kil Hong. J Korean Neurosurg Soc / 2015

O(6)-methylguanine-DNA-methyltransferase promoter methylation assessment by microdissection-assisted methylation-specific PCR and high resolution melting analysis in patients with glioblastomas. Yang SH, Lee KS, Yang HJ, Jeon BH, Lee YS, Nam SW, Chung DS, Lee SW, Hong YK. J Neurooncol. 106(2):243-50. 2012.

Enhancement of anti-tumorimmunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12. Kim CH, Hong MJ, Park SD, Kim CK, Park MY, Sohn HJ, Cho HI, Kim TG, Hong YK. Cancer Immunol Immunother. 55:1309-1319. 2006.

Anti-angiogenic activity of the recombinant kringle domain of urokinase and its endothelial cell specific entry. Kwang Sei Kim, Yong-Kil Hong, Young Ae Joe, Yoon Lee, Joo-Young Shin, Il-Ha Lee, Soo-Young Lee, Dong-Ku Kang, Soo-Ik Chang, and Soo II Chung. J Biol Chem 278(13):11449-11456, 2003.

Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas. Kim IA, Yang YJ, Yoon SC, Choi IB, Kay CS, Kwon HC, Kim CM, Joe YA, Kang JK, Hong YK. Int J Oncol 19(5):1041-7, 2001.

Efficient inhibition of in vivo malignant glioma growth and angiogenesis by interferon-b treatment at early stage of tumor development. Hong Y-K, Chung D-S, Joe Y-A, Yang Y-J, Park Y-S, Kim K-M, Yung WKA, Kang J-K. Clin Cancer Res. 6(8):3354-60, 2000.

Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3. Joe YA, Hong YK, Chung DS, Yang YJ, Kang JK, Lee YS, You WK, Lee HS, Chung SI. Int J Cancer. 82(5):694-699, 1999.